Literature DB >> 9704289

Dysfunction of the hypothalamic-pituitary system in mitochondrial encephalomyopathies.

N Ohkoshi1, A Ishii, N Shiraiwa, S Shoji, K Yoshizawa.   

Abstract

We investigated endocrine function in patients with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS), myoclonus epilepsy associated with ragged-red fibers (MERRF), and chronic progressive external ophthalmoplegia (CPEO). Hypothalamic-pituitary function was impaired in all three patients with MELAS or MERRF, but none of four with CPEO. A MELAS patient with dwarfism and impaired adolescent development had decreased growth hormone, luteinizing hormone (LH), and follicle-stimulating hormone (FSH). A MERRF patient had emaciation and low adrenocorticotropin. A patient with mitochondrial encephalomyopathy transitional between MELAS and MERRF showed delayed, blunted LH and FSH response to LH-releasing hormone stimulation. We concluded that patients with mitochondrial encephalomyopathies, especially MELAS or MERRF, are likely to have hypothalamic-pituitary dysfunction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9704289

Source DB:  PubMed          Journal:  J Med        ISSN: 0025-7850


  7 in total

Review 1.  The neuro-ophthalmology of mitochondrial disease.

Authors:  J Alexander Fraser; Valérie Biousse; Nancy J Newman
Journal:  Surv Ophthalmol       Date:  2010-05-14       Impact factor: 6.048

Review 2.  The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: a review of treatment options.

Authors:  Fernando Scaglia; Jennifer L Northrop
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

3.  Cerebrospinal fluid neurone-specific enolase in mitochondrial encephalomyopathies.

Authors:  Josef Finsterer; Markus Exner; Helmut Rumpold
Journal:  Metab Brain Dis       Date:  2005-03       Impact factor: 3.584

Review 4.  Mitochondrial disease and endocrine dysfunction.

Authors:  Jasmine Chow; Joyeeta Rahman; John C Achermann; Mehul T Dattani; Shamima Rahman
Journal:  Nat Rev Endocrinol       Date:  2016-10-07       Impact factor: 43.330

5.  Photosensitive Epilepsy and Polycystic Ovary Syndrome as Manifestations of MERRF.

Authors:  Josef Finsterer
Journal:  Case Rep Neurol Med       Date:  2020-09-28

6.  Rare Phenotypic Manifestations of MELAS.

Authors:  Josef Finsterer
Journal:  Yonsei Med J       Date:  2020-10       Impact factor: 2.759

Review 7.  Endocrine disorders in mitochondrial disease.

Authors:  Andrew M Schaefer; Mark Walker; Douglass M Turnbull; Robert W Taylor
Journal:  Mol Cell Endocrinol       Date:  2013-06-13       Impact factor: 4.102

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.